180 related articles for article (PubMed ID: 36085200)
1. Deubiquitinase OTUD5 modulates mTORC1 signaling to promote bladder cancer progression.
Hou T; Dan W; Liu T; Liu B; Wei Y; Yue C; Que T; Ma B; Lei Y; Wang Z; Zeng J; Fan Y; Li L
Cell Death Dis; 2022 Sep; 13(9):778. PubMed ID: 36085200
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways.
Cho JH; Kim K; Kim SA; Park S; Park BO; Kim JH; Kim SY; Kwon MJ; Han MH; Lee SB; Park BC; Park SG; Kim JH; Kim S
Cell Death Differ; 2021 Mar; 28(3):900-914. PubMed ID: 33110214
[TBL] [Abstract][Full Text] [Related]
3. The RING-type E3 ligase RNF186 ubiquitinates Sestrin-2 and thereby controls nutrient sensing.
Lear TB; Lockwood KC; Ouyang Y; Evankovich JW; Larsen MB; Lin B; Liu Y; Chen BB
J Biol Chem; 2019 Nov; 294(45):16527-16534. PubMed ID: 31586034
[TBL] [Abstract][Full Text] [Related]
4. E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression.
Wang D; Xu C; Yang W; Chen J; Ou Y; Guan Y; Guan J; Liu Y
Mol Cell; 2022 Feb; 82(4):770-784.e9. PubMed ID: 35114100
[TBL] [Abstract][Full Text] [Related]
5. OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1.
Yang Y; Jia S; Zhu N; Xiao X; Ma Y; Tu K; Guo Y; Xu Q
Biol Direct; 2024 Apr; 19(1):31. PubMed ID: 38658981
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin E3 ligase Atrogin-1 protein is regulated via the rapamycin-sensitive mTOR-S6K1 signaling pathway in C2C12 muscle cells.
Nishimura Y; Chunthorng-Orn J; Lord S; Musa I; Dawson P; Holm L; Lai YC
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C215-C225. PubMed ID: 35704697
[TBL] [Abstract][Full Text] [Related]
7. The anticancer effects of curcumin via targeting the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway.
Tamaddoni A; Mohammadi E; Sedaghat F; Qujeq D; As'Habi A
Pharmacol Res; 2020 Jun; 156():104798. PubMed ID: 32278045
[TBL] [Abstract][Full Text] [Related]
8. The E3 ubiquitin ligase protein associated with Myc (Pam) regulates mammalian/mechanistic target of rapamycin complex 1 (mTORC1) signaling in vivo through N- and C-terminal domains.
Han S; Kim S; Bahl S; Li L; Burande CF; Smith N; James M; Beauchamp RL; Bhide P; DiAntonio A; Ramesh V
J Biol Chem; 2012 Aug; 287(36):30063-72. PubMed ID: 22798074
[TBL] [Abstract][Full Text] [Related]
9. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling.
Wang B; Jie Z; Joo D; Ordureau A; Liu P; Gan W; Guo J; Zhang J; North BJ; Dai X; Cheng X; Bian X; Zhang L; Harper JW; Sun SC; Wei W
Nature; 2017 May; 545(7654):365-369. PubMed ID: 28489822
[TBL] [Abstract][Full Text] [Related]
10. Effect of Deubiquitinase Ovarian Tumor Domain-Containing Protein 5 (OTUD5) on Radiosensitivity of Cervical Cancer by Regulating the Ubiquitination of Akt and its Mechanism.
Yin F; He H; Zhang B; Zheng J; Wang M; Zhang M; Cui H
Med Sci Monit; 2019 May; 25():3469-3475. PubMed ID: 31075090
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-specific peptidase 9, X-linked (USP9X) modulates activity of mammalian target of rapamycin (mTOR).
Agrawal P; Chen YT; Schilling B; Gibson BW; Hughes RE
J Biol Chem; 2012 Jun; 287(25):21164-75. PubMed ID: 22544753
[TBL] [Abstract][Full Text] [Related]
12. OTUB1 protein suppresses mTOR complex 1 (mTORC1) activity by deubiquitinating the mTORC1 inhibitor DEPTOR.
Zhao L; Wang X; Yu Y; Deng L; Chen L; Peng X; Jiao C; Gao G; Tan X; Pan W; Ge X; Wang P
J Biol Chem; 2018 Mar; 293(13):4883-4892. PubMed ID: 29382726
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of OTUD5 in non-small cell lung cancer cell proliferation, invasion, and migration.
Li X; Lu B; Zhang L; Yang J; Cheng Y; Yan D
Bosn J Basic Med Sci; 2022 Oct; 22(6):901-911. PubMed ID: 35765958
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinase OTUD5 promotes hepatitis B virus replication by removing K48-linked ubiquitination of HBV core/precore and upregulates HNF4ɑ expressions by inhibiting the ERK1/2/mitogen-activated protein kinase pathway.
Lou B; Ma G; Yu X; Lv F; Xu F; Sun C; Chen Y
Cell Mol Life Sci; 2023 Oct; 80(11):336. PubMed ID: 37897511
[TBL] [Abstract][Full Text] [Related]
15. mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase.
Ghosh P; Wu M; Zhang H; Sun H
Cell Cycle; 2008 Feb; 7(3):373-81. PubMed ID: 18235224
[TBL] [Abstract][Full Text] [Related]
16. UBE2S exerts oncogenic activities in urinary bladder cancer by ubiquitinating TSC1.
Tang H; Fang T; Ji M; Wang JP; Song LL; Zhang QY; Wu JS
Biochem Biophys Res Commun; 2021 Nov; 578():7-14. PubMed ID: 34520980
[TBL] [Abstract][Full Text] [Related]
17. The Regulation and Double-Edged Roles of the Deubiquitinase OTUD5.
Fu L; Lu K; Jiao Q; Chen X; Jia F
Cells; 2023 Apr; 12(8):. PubMed ID: 37190070
[TBL] [Abstract][Full Text] [Related]
18. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma.
Jhanwar-Uniyal M; Dominguez JF; Mohan AL; Tobias ME; Gandhi CD
Adv Biol Regul; 2022 Jan; 83():100854. PubMed ID: 34996736
[TBL] [Abstract][Full Text] [Related]
19. Oxysterol-binding protein-related protein 5 (ORP5) promotes cell proliferation by activation of mTORC1 signaling.
Du X; Zadoorian A; Lukmantara IE; Qi Y; Brown AJ; Yang H
J Biol Chem; 2018 Mar; 293(10):3806-3818. PubMed ID: 29358326
[TBL] [Abstract][Full Text] [Related]
20. The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168.
Xie X; Hu H; Tong X; Li L; Liu X; Chen M; Yuan H; Xie X; Li Q; Zhang Y; Ouyang H; Wei M; Huang J; Liu P; Gan W; Liu Y; Xie A; Kuai X; Chirn GW; Zhou H; Zeng R; Hu R; Qin J; Meng FL; Wei W; Ji H; Gao D
Nat Cell Biol; 2018 Mar; 20(3):320-331. PubMed ID: 29403037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
